Rating History for Alder Biopharm (ALDR) by Leerink Partners
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/17/2019 | Marc Goodman | Downgrade | Market Perform (Outperform) |
20.00 (21.00) |
10.06 (18.88) |
87.67% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
